•
Dec 31, 2022

Solid Biosciences Q4 2022 Earnings Report

Total Revenue
$8.09M
Previous year: $3.15M
+156.6%
EPS
-$0.68
Previous year: -$2.55
-73.3%
Gross Profit
$7.56M
Previous year: -$41M
-118.4%
Cash and Equivalents
$155M
Previous year: $119M
+30.4%
Free Cash Flow
-$35.3M
Previous year: -$21.5M
+64.1%
Total Assets
$260M
Previous year: $232M
+12.0%

Solid Biosciences

Solid Biosciences